TRNS Company Profile and Key Details

Transcat, Inc. (NASDAQ:TRNS) closed at $86.49 USD, gaining $0.64 (0.75%) from the previous close of $85.85. The stock is currently mid-range between its 52-week high and low $50.23 and $100.00. With a market capitalization of about $809.53 million, Transcat, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.67). Key stats such as the average daily volume over the past year has been around 152.27 thousand shares, volume is running light vs its 52-week average. Headquartered in Rochester, NY, Transcat, Inc. operates in the Industrials sector and the Specialty Business Services industry. Led by CEO Jaime A. Irick, the company employs approximately 1,413 people and listed since December 05, 1977. Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation.

Short-term trend indicators are mixed aligned (SMA20 4.0%, SMA50 15.93%, SMA200 5.02%). The stock’s 14-day RSI is 61.7 (firm momentum), while the ATR of 3.4 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -21.19% below its high and over 52.32% above its low. Average 10-day trading volume of 117.54 thousand shares is below the 3-month average of 155.60 thousand, indicating normal recent market interest.

Transcat, Inc. generated EPS of $0.84 over the past year. Five-year average earnings growth is 7.8%. Wall Street analysts project EPS growth of -2.08% annually over the next five years. The latest quarter delivered EPS of $0.51. The next quarter is forecast at $0.56. Next year's EPS is expected at $7.21. Transcat, Inc. earnings surprise history is a mixed track record. The quarter that ended August 04, 2026, missed forecasts by 35.1%. The prior quarter beat by 9.8%. Over the last six quarters, Apple has recorded several small beats. These include -3.03% in May 19, 2025.

Transcat, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $91.49. This means the shares are trading below this model’s fair value.

Transcat, Inc. has 9.36 million shares outstanding. The public float is 9.13 million shares, elevated short interest at 7.13% of float. This equals 517.55 thousand shares. The short ratio is 3.98 days. Institutional investors hold 107.33% of the float. Insiders own 2.39%. Rudow Lee D. holds 91.69 thousand shares, MOORE PAUL D has 45.49 thousand shares and SASSANO CARL E has 45.10 thousand shares. Over the past six months, insider transactions show balanced activity. They sold 504.00 shares across 1 transactions.

Transcat, Inc. trades at a P/E ratio of 231.58, slightly above the S&P 500 average, with a price-to-sales ratio of 2.3 and a price-to-book ratio of 2.65 suggesting the stock is closer to book value. The P/FCF stands at 31.65, also above market averages.

Transcat, Inc. (NASDAQ:TRNS) shares are up 10.63% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Transcat, Inc. trading at a premium to the broader market with a P/E of 231.58. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $82.54, suggesting -4.57% downside. Our AI forecast model points to short-term weakness (-7.39% over two weeks), a medium-term fall (-52.21% over three months), and a longer-term loss (-13.7% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Transcat, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -7.39%, with price expected at $80.10 by September 14, 2026, within a range of $76.63 to $83.61 3-Month Outlook: Projected fall of -52.21%, reaching $41.33 by November 26, 2026, with a range of $36.16 to $44.75. 1-Year Outlook: Projected loss of -13.7%, with price at $74.64 by August 31, 2027, within a range of $67.97 to $80.18.